FluoroPharma Medical Share Holder Equity 2010-2016 | FPMI
FluoroPharma Medical share holder equity from 2010 to 2016. Share holder equity can be defined as the sum of preferred and common equity items
| FluoroPharma Medical Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2016 | $-10 |
| 2015 | $-8 |
| 2014 | $-5 |
| 2013 | $-1 |
| 2012 | $1 |
| 2011 | $3 |
| 2010 | $-2 |
| 2009 | $0 |
| FluoroPharma Medical Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2016-12-31 | $-10 |
| 2016-09-30 | $-10 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-7 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-5 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $0 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $2 |
| 2012-03-31 | $3 |
| 2011-12-31 | $3 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $0 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.000B | $0.000B |
| FluoroPharma Medical, Inc. is engaged in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company's initial focus is the development of positron emission tomography imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease. Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, amyloid plaque in Alzheimer's disease and agents for detection of certain types of cancer. FluoroPharma Medical, Inc. is headquartered in Boston, Massachusetts. | |||